O Positiv Reportedly Explores Sale Valued at Around US$1 Billion
Women’s health supplements brand O Positiv is exploring a potential sale that could value the company at approximately US$1 billion, according to sources familiar with the matter. The post O Positiv Reportedly Explores Sale Valued at Around US$1 Billion appeared first on Global Cosmetics News.

THE WHAT? Women’s health supplements brand O Positiv is exploring a potential sale that could value the company at approximately US$1 billion, according to sources familiar with the matter.
THE DETAILS The founder-owned business is said to be working with investment bank Jefferies on the process. O Positiv is reportedly projecting US$275 million in revenue for 2025, up from around US$225 million in 2024. Founded in 2018, the company formulates vitamins and probiotics addressing PMS, menopause, vaginal health, and gut health. Its products are sold online and through select retail partners. No deal has been finalised, and both O Positiv and Jefferies declined to comment on the
THE WHY? Interest in women’s health and wellness brands has grown among both strategic buyers and private equity firms, with recent acquisitions including Pharmavite’s purchase of Bonafide and L Catterton’s investment in Stripes. O Positiv’s presence in the supplement space positions it within this broader sector trend.
Source: Reuters
The post O Positiv Reportedly Explores Sale Valued at Around US$1 Billion appeared first on Global Cosmetics News.